Long-term management of unprovoked venous thromboembolism | medReha
3883
post-template-default,single,single-post,postid-3883,single-format-standard,bridge-core-3.0.2,qode-page-transition-enabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-28.8,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,wpb-js-composer js-comp-ver-6.9.0,vc_responsive

Long-term management of unprovoked venous thromboembolism

Long-term management of unprovoked venous thromboembolism

To find out about the most recent advances in this domain, we sat down with the senior author of the ASPIRE trial — for Aspirin to Prevent recurrent Venous Thromboembolism.

Dr. Timothy Brighton, from the Prince of Wales Hospital in Australia, led us through the details of the study

http://www.md-fm.com/index.php?op=Player&id=823&log=e21cf051d5f60621c3869fd05e787991&spec=0

 

Share